Navigation Links
Breakthrough In Tasmanian Devil Disease

Scientists in northern Tasmania have revealed that they might have made a breakthrough in the mystifying tumor disease affecting Tasmanian devils. // These tumors spread by biting and feeding and could also be transferred when the animals are mating, the researchers said.

Devil researcher Anne-Maree Pearse from the state's Primary Industries Department said that unlike most cancers these tumors do not grow from the tissue of the affected devil, "What we've shown, or we've shown a lot of very strong evidence that the cancer is transmitted from animal to animal during fighting and biting, but by an infectious cancer cell line ... that is incredibly unusual," she observed. Alistair Scot, who leads the project for the devil disease said that these new findings would help them get a clearer picture of the facial tumors in these animals, "The possibility of transmission through a virus or through airborne vector and those sort of things we have had on the table, but this very much puts the focus on to the physical transmission with the cancer being transmitted from devil to devil," he said. Environment Department's Nick Mooney said that even with these new findings, the animals will continue to be susceptible for some time to come. "I mean the history of diseases like this is that some animals are resistant to a disease - I mean it doesn't matter what infectious disease it is usually," he said. "It is an animal resistance [which is the] same that applies to people and so what often happens is the [extent to which the] animal population goes down to various degrees depends on the disease then builds up again from the animals that have some sort of natural resistance."
'"/>




Page: 1

Related medicine news :

1. Sperm washing helps couples – Breakthrough in focu
2. ZD1839 Proves Effective - A Breakthrough in fighting Lung Cancer
3. Breakthrough in eye treatment
4. Genetic Breakthrough in Common Eye Problem
5. Breakthrough in cancer therapy
6. Breakthrough in Type II Diabetes
7. Breakthrough In Stem Cell Work
8. A Likely Breakthrough For Prostate Cancer Patients
9. New DNA Breakthrough Can Change Future Of Medicine
10. Breakthrough In New Vaccine For Malaria
11. Medical Breakthrough - Kidney Transplant Recipient Survives Without Drugs
Post Your Comments:
(Date:12/5/2008)...fer heart problems, study says , , FRIDA...ly lung disease idiopathic pulmonary fibrosis (IPF...the disease to suffer severe cardiac events such a..., "If you look at them over time, people with IP... coronary syndrome, which is a greater increase th...
(Date:12/5/2008)...For many, city living is at its,finest during the...rther,glamorized by the festive parties, larger t...the joyful atmosphere. However, for many single ci...an emotionally trying time,filled with expectatio...,romance during the holidays have developed a neg...
(Date:12/5/2008)...- Norgine, the leading European specialty pharmace...anted Medical Futures the exclusive rights to mark... patent-protected product developed by Norgine for...tuations where a clean bowel is required. The prod...A by its partner Salix Pharmaceuticals. , In re...
(Date:12/5/2008).../ - QLT Inc. (NASDAQ: QLTI ; TSX: QLT) announced... bid circular (the "Circular") to its shareholders...n" tender offer for up to US$50 million of common ...The Circular is being filed with the securities re...da. Under the terms of the tender offer, sharehold...
Breaking Medicine News(10 mins):Health News:Lung Disease Tied to Increased Risk for Cardiac Events 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 2Health News:Single in the City? How the Holidays Leave the Fabulous Feeling More Like Failures 3Health News:Medical Futures partners with Norgine for MOVIPREP(R) in Canada 2Health News:QLT announces commencement of tender offer 2Health News:QLT announces commencement of tender offer 3Health News:QLT announces commencement of tender offer 4Health News:QLT announces commencement of tender offer 5
...t enabled gay men contact in Hong Kong has been in...according to a latest report. // Government healt... 2003 and November 2005, had HIV with similar gene...a Morning Post reported. The discovery was made w...
...ted among Americans has revealed that most of them... to a mere chance. The results of the study may no...rns about sex selection may be prevalent, leading ...und that only eight percent of people would use pr...
...t three feet tall and 37 pound in weight prior to... baby is her first child. // Eloysa Vasquez, conf...is imperfecta , a disorder that has rendered her b... had two miscarriages as well. During the pregnan...
...a mental health court, the first one of its kind i... motive to pick // out sober and non violent defen... them to languish in the jails. U.S. House Speake...,000 fund to help with administration of Kane Coun...
Other Medicine News:Health News:Americans Not Interested In Choosing Sex Of Child: Survey 2
(Date:12/3/2008).... Jude treatment alleviates long-term anemia and o...plications , , MEMPHIS, Tenn., Dec. 3 /PRN...nsert a corrective gene into mouse blood cells, sc...have alleviated sickle cell disease pathology. In ...ted mice showed essentially no difference from nor...
(Date:12/3/2008)..., Del., Dec. 3 Isogen, a contract ...erile filling, announced it has retained a,strate... to meet the global,biopharma demand for Isogen,s...d a successful first round series of capital,inve...acility in Q1 2009 to,deliver on the previously u...
(Date:12/3/2008)...EGO, Dec. 3 Vical Incorp...sive, binding letter of intent with EIP,Eczacibas...g of the company,s,Allovectin-7(R) immunotherapeu...epublic of Northern Cyprus. EIP has agreed to obta...ritory and to pay Vical upfront and milestone paym...
(Date:12/2/2008)...DGE, Mass., Dec. 2 Biopu...that the U.S. Naval Medical Research Center,(NMRC...n (FDA) a revised,investigational new drug (IND) ...mpany,s oxygen therapeutic Hemopure(R) [hemoglobin...ttlefield treatment of trauma patients. The study ...
Breaking Medicine Technology:Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 2Gene Therapy Corrects Sickle Cell Disease in Laboratory Study 3Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 2U.S. Naval Medical Research Center Resubmits IND Application for Proposed 'Op RESUS' Clinical Trial in Trauma Patients in the Battlefield Setting 3Sage Software Healthcare Inc Announces Intergy by Sage and Intergy EHR by Sage installations for 2007 7649 1Sage Software Healthcare Inc Announces Intergy by Sage and Intergy EHR by Sage installations for 2007 7649 2Infant Development Program from EASY Baby Takes On the Sixty Percent Increase in Developmental Delays in Children 7647 1Infant Development Program from EASY Baby Takes On the Sixty Percent Increase in Developmental Delays in Children 7647 2Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 1Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 2Advances in Blood Cancer Therapy to be Highlighted at American Society of Hematology Conference 7645 3Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 1Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 2Teen Birth Rates Up for First Time in 14 Years U S Reports 7643 3
...PARK, Calif.--(BUSINESS WIRE)--Jun 11, 2007 - Gero...esentation of,research studies indicating that GRN...C)-based therapeutic for the treatment of,spinal c...mune,system., Presented by Geron scientist Ross Ok...ieties meeting in San Diego, the findings,could me...
...he Netherlands, June 11, 2007-Sugammadex - the nov...eveloped by Organon,the human healthcare business...pivotal trial a 9-12 times faster reversal of,neur...hout evidence,of post operative residual curarizat..., 2 The results of this pivotal Aurora trial,were ...
Other Medicine Technology:Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 2Research Indicates Geron's Human Embryonic Stem Cell-Based,Therapeutic for Spinal Cord Injury Evades Direct Attack by the,Human Immune System 3Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 2Organon's Sugammadex Demonstrated a 9-12 Times Faster Recovery in,Phase III Pivotal Trial Compared to Neostigmine 3
...ne-125 implant is a combination of innovative desi...e visibility that makes BrachySource I-125 implant...You can be confident that every BrachySource I-125...rvices which is required by clinicians who must me...
...ne-125 implant is a combination of innovative desi...e visibility that makes BrachySource I-125 implant...You can be confident that every BrachySource I-125...rvices which is required by clinicians who must me...
The Double-J Closed Tip Ureteral Stent design revolutionized stenting over 15 years ago. Today, it remains one of the most widely used stents in the world. An exclusive ACMI design allows one-step in
...ternal drainage from the ureteropelvic junction to...e segment with no sideports prevents postoperative...ingrowth of the ureteral wall to the stent. Suppli...-time use. CAUTION: Periodic evaluation is advised...
Medicine Products: